Anti-Human CSF1R Therapeutic Antibody (Cabiralizumab)

Recombinant monoclonal antibody to CSF1R. Cabiralizumab is a human monoclonal antibody that can be potentially used in the treatment of Rheumatoid arthritis (RA), Pigmented villonodular synovitis (PVNS).
Supplier Creative Biolabs
Product # TAB-011ML
Pricing Inquiry
Host Human
Target CSF1R
Species Reactivity Human
Type IgG4, κ
Applications Used for immunoassay techniques such as: Enzyme-Linked Immunosorbent Assay; Immunohistochemistry; Immunofluorescence; Immunoprecipitation; Flow Cytometry; Inhibition
Storage Store at -20°C for long-term storage. Avoid freeze/thaw cycles.
Feedback